India's Jubilant Pharmova falls on lower Q1 profit
** Shares of Jubilant Pharmova JUBA.NS fall as much as
4.6% to 380 rupees
** Stock hits lowest level since June 15
** Co's Q1 consolidated net profit fell 86.4% to 64 million
rupees ($779,236.28)
** Total expenses in the June-quarter rose to 12.6% from a
year earlier
** More than 598,000 shares traded by 2:18 p.m. IST, 2.9
times their 30-day average
** Up to last close, stock up 6.2% YTD
($1 = 82.1317 Indian rupees)
(Reporting by Navamya Ganesh Acharya in Bengaluru)
((Navamya.GaneshAcharya@thomsonreuters.com; +91 8805175330 ;))
Recent news on Jubilant Pharmova
See all newsBrief: Jubilant Pharmova Sept-Quarter Consol Net Profit 312 Million Rupees
Brief: Jubilant Pharmova Says Jubilant Therapeutics Announces Oral Presentation Of Preliminary Phase 1 Clinical Data For JBI-802
India New Issue-Jubilant Pharmova to issue 3-year bonds, bankers say
India's Jubilant Pharmova eyes $150 mln through rupee debt sale, bankers say
Brief: Jubilant Pharmova To Consider Raising Of Funds Through Issuance Of Non- Convertible Debentures